Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Trade Groups Weigh In On FTC/DOJ Intellectual Property Report

This article was originally published in The Tan Sheet

Executive Summary

Intellectual property and antitrust policy under consideration by the Federal Trade Commission and the Department of Justice addresses dietary supplement industry concerns, according to trade group executives who ask for more consistency in IP protection laws

You may also be interested in...



Trimming Patent Application Review Backlog Takes Center Stage In Reform

While improvements in patent and IP protection are sought by the dietary supplement and other industries, the "real issue" is the backlog of cases before the Patent and Trademark Office, said Daniel Fabricant, the Natural Products Association's vice president for scientific and regulatory affairs

Trimming Patent Application Review Backlog Takes Center Stage In Reform

While improvements in patent and IP protection are sought by the dietary supplement and other industries, the "real issue" is the backlog of cases before the Patent and Trademark Office, said Daniel Fabricant, the Natural Products Association's vice president for scientific and regulatory affairs

Trimming Patent Application Review Backlog Takes Center Stage In Reform

While improvements in patent and IP protection are sought by the dietary supplement and other industries, the "real issue" is the backlog of cases before the Patent and Trademark Office, said Daniel Fabricant, the Natural Products Association's vice president for scientific and regulatory affairs

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100511

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel